her semaglutide Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Despite the Stigma, Hims &

Our program is designed for adults ready to approach weight loss with a practical, wellness-centered mindset

Your healthcare provider will help guide you through the dosages, but it can be a little confusing at first

An independent licensed medical provider reviews your health information and makes a clinical determination about whether GLP-1 treatment is appropriate for you

Working with your healthcare provider The decision to stop a GLP-1 should always be collaborative

Individualized Considerations The choice between Mounjaro and Retatrutide ultimately depends on the individual's specific needs, preferences, and overall health profile

Advertisement With this dual agonism, tirzepatide has demonstrated the largest weight loss in a randomized trial of any medication for obesity/overweight to date, with its highest dose achieving a 22.5% reduction relative to placebo at 72 weeks in the phase 3 SURMOUNT-1 trial ( N Engl J Med